Abstract
A 23-year-old woman has medically refractory focal epilepsy with and without secondary generalized tonic-clonic seizures. Her seizures have been controlled in the past 2 years on a combination of topiramate 200 mg twice daily and levetiracetam 1500 mg twice daily. Previous attempts to lower or simplify her medication regimen resulted in seizure recurrence. She has tried oxcarbazepine and lamotrigine in the past with no success. During her visit, she brings up the fact that she desires to become pregnant and start a family. How do you counsel the patient regarding the risks for teratogenicity of her seizure medications and what do you advise her to do?
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tanganelli P, Regesta G. Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study. Neurology. 1992;42(4 Suppl 5):89–93.
Hiilemsa VK, Teramo K, Bardy AH. Social class, complications, and perinatal deaths in pregnancies of epileptic women: preliminary results of the prospective Helsinki study. In: Janz D, editor. Epilepsy, pregnancy, and the child. New York: Raven; 1982. p. 53–9.
Nei M, Daly S, Liporace J. A maternal complex partial seizure in labor can affect fetal heart rate. Neurology. 1998;51(3):904–6.
Sahoo S, Klein P. Maternal complex partial seizure associated with fetal distress. Arch Neurol. 2005;62(8):1304–5.
Hunt S, Russell A, Smithson WH, et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology. 2008;71(4):272–6.
Margulis AV, Mitchell AA, Gilboa SM, et al. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol. 2012;207(5):405e1–7.
Mawhinney E, Craig J, Morrow J, et al. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology. 2013;80(4):400–5.
Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360(16):1597–605.
Wood AG, Nadebaum C, Anderson V, et al. Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy. Epilepsia. 2015;56(7):1047–55.
Shallcorss R, Bromley RL, Cheyne CP, et al. In utero exposure to levetiracetam versus valproate: development and language at 3 years of age. Neurology. 2014;82(3):213–21.
Tomson T, Xue H, Battino D. Major congenital malformations in children of women with epilepsy. Seizure. 2015;28:46–50. http://dx.doi.org/10.1016/j.seizure.2015.02.019.
Veiby G, Daltveit AK, Engelsen BA, et al. Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J Neurol. 2014;261(3):579–88.
Bromley R, Weston J, Adab N, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev. 2014;10:CD010236. doi:10.1002/14651858.CD010236.pub2.
Alsaad AMS, Chaudhry SA, Koren G. First trimester exposure to topiramate and the risk of oral clefts in the offspring: a systematic review and meta-analysis. Reprod Toxicol. 2015;53:45–50. http://dx.doi.org/10.1016/j.reprotrox.2015.03.003.
Teramo K, Hiilesmaa V, Bardy A, Saarikoski S. Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med. 1979;7:3–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Friedman, D.E., Tomson, T., Sazgar, M. (2016). Seizure Medications and Teratogenicity. In: Sazgar, M., Harden, C. (eds) Controversies in Caring for Women with Epilepsy. Springer, Cham. https://doi.org/10.1007/978-3-319-29170-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-29170-3_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29168-0
Online ISBN: 978-3-319-29170-3
eBook Packages: MedicineMedicine (R0)